169 related articles for article (PubMed ID: 34866303)
21. Yolk sac tumor of vagina: a case report.
Alhumidi A; Al Shaikh S; Alhammadi A
Int J Clin Exp Pathol; 2015; 8(2):2183-5. PubMed ID: 25973124
[TBL] [Abstract][Full Text] [Related]
22. Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children's cancer group.
Cushing B; Giller R; Ablin A; Cohen L; Cullen J; Hawkins E; Heifetz SA; Krailo M; Lauer SJ; Marina N; Rao PV; Rescorla F; Vinocur CD; Weetman RM; Castleberry RP
Am J Obstet Gynecol; 1999 Aug; 181(2):353-8. PubMed ID: 10454682
[TBL] [Abstract][Full Text] [Related]
23. Ovarian yolk sac tumour in a girl - case report.
Sharma C; Shah H; Sisodiya Shenoy N; Makhija D; Waghmare M
Dev Period Med; 2017; 21(2):101-103. PubMed ID: 28796980
[TBL] [Abstract][Full Text] [Related]
24. Germ Cell Tumors of the Female Genital Tract.
Euscher ED
Surg Pathol Clin; 2019 Jun; 12(2):621-649. PubMed ID: 31097117
[TBL] [Abstract][Full Text] [Related]
25. Pitfalls in management of patients with germ cell tumors and slight elevation of serum α-fetoprotein.
Albany C; Einhorn L
J Clin Oncol; 2014 Jul; 32(19):2114-5. PubMed ID: 24841979
[No Abstract] [Full Text] [Related]
26. Germ cell tumors. Case 3. Primary yolk sac tumor of the liver.
Toumi N; Chaumette-Plankaert MT; Cherqui D; de Revel T; Duvillard P; Theodore C
J Clin Oncol; 2004 May; 22(9):1756-8. PubMed ID: 15118001
[No Abstract] [Full Text] [Related]
27. Lectin-reactive alpha-fetoprotein (AFP-L3%) curability and prediction of clinical course after treatment of non-seminomatous germ cell tumors.
Kamoto T; Satomura S; Yoshiki T; Okada Y; Henmi F; Nishiyama H; Kobayashi T; Terai A; Habuchi T; Ogawa O
Jpn J Clin Oncol; 2002 Nov; 32(11):472-6. PubMed ID: 12499420
[TBL] [Abstract][Full Text] [Related]
28. Unusual anatomic location of a primary intracranial yolk sac tumor.
Al-Masri AA; Khasawneh NH; Aladily TN
Ann Saudi Med; 2011; 31(3):298-300. PubMed ID: 21293065
[TBL] [Abstract][Full Text] [Related]
29. α-Fetoprotein as a predictor of outcome for children with germ cell tumors: A report from the Malignant Germ Cell International Consortium.
O'Neill AF; Xia C; Krailo MD; Shaikh F; Pashankar FD; Billmire DF; Olson TA; Amatruda JF; Villaluna D; Huang L; Malogolowkin M; Rodriguez-Galindo C; Frazier AL
Cancer; 2019 Oct; 125(20):3649-3656. PubMed ID: 31355926
[TBL] [Abstract][Full Text] [Related]
30. Clinical analysis of management of pediatric testicular germ cell tumors.
Ye YL; Sun XZ; Zheng FF; Bian J; Huang YP; Zhang XQ; Li ZX; Nie Y; Qin ZK; Dai YP
Urology; 2012 Apr; 79(4):892-7. PubMed ID: 22305424
[TBL] [Abstract][Full Text] [Related]
31. [A case report for primary yolk sac tumor of endometrium].
Hu Y; Zeng F; Xue M; Xiao S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 41(12):1362-1365. PubMed ID: 28070053
[TBL] [Abstract][Full Text] [Related]
32. A mediastinal germ cell tumor of yolk sac type--case report.
Tinica G; Butcovan D; Cimpeanu C; Târcoveanu E
Chirurgia (Bucur); 2010; 105(6):831-4. PubMed ID: 21351701
[TBL] [Abstract][Full Text] [Related]
33. Many postchemotherapy sarcomatous tumors in patients with testicular germ cell tumors are sarcomatoid yolk sac tumors: a study of 33 cases.
Howitt BE; Magers MJ; Rice KR; Cole CD; Ulbright TM
Am J Surg Pathol; 2015 Feb; 39(2):251-9. PubMed ID: 25229769
[TBL] [Abstract][Full Text] [Related]
34. [Malignant germ cell tumours. Multicenter prospective trial in Polish Pediatric Group for Solid Tumours (years 1998-2000)].
Popadiuk S; Korzon M; Szumera M; Chybicka A; Szmyd K; Dzierzega M; Kowalczyk JR; Wiśniewska-Slusarz H; Trelińska J; Wozniak W; Bilska K; Wysocki M; Krawczuk-Rybak M; Lopatka B
Przegl Lek; 2004; 61 Suppl 2():29-32. PubMed ID: 15686043
[TBL] [Abstract][Full Text] [Related]
35. Glypican 3 has a higher sensitivity than alpha-fetoprotein for testicular and ovarian yolk sac tumour: immunohistochemical investigation with analysis of histological growth patterns.
Zynger DL; McCallum JC; Luan C; Chou PM; Yang XJ
Histopathology; 2010 May; 56(6):750-7. PubMed ID: 20546340
[TBL] [Abstract][Full Text] [Related]
36. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma.
Cao D; Guo S; Allan RW; Molberg KH; Peng Y
Am J Surg Pathol; 2009 Jun; 33(6):894-904. PubMed ID: 19295406
[TBL] [Abstract][Full Text] [Related]
37. Primary yolk sac (endodermal sinus) tumour of the vulva: a case report.
Subrahmanya NB; Kapadi SN; Junaid TA
Med Princ Pract; 2011; 20(1):90-2. PubMed ID: 21160222
[TBL] [Abstract][Full Text] [Related]
38. Lectin affinity electrophoresis in a yolk sac tumour in the vagina with yolk sac tumour-type glycoform of alpha fetoprotein.
Yamamoto R; Taketa K; Ebina Y; Cho Y; Hareyama H; Sakuragi N; Makinoda S; Kobayashi K; Nishi S; Fujimoto S
J Clin Pathol; 1997 Oct; 50(10):856-8. PubMed ID: 9462270
[TBL] [Abstract][Full Text] [Related]
39. Ovarian mucinous cystadenocarcinoma with yolk sac tumor in a 71-year-old woman.
Arai T; Kitayama Y; Koda K
Int J Gynecol Pathol; 1999 Jul; 18(3):277-80. PubMed ID: 12090598
[TBL] [Abstract][Full Text] [Related]
40. Actual half-life of alpha-fetoprotein as a prognostic tool in pediatric malignant tumors.
Han SJ; Yoo S; Choi SH; Hwang EH
Pediatr Surg Int; 1997; 12(8):599-602. PubMed ID: 9354734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
